October 23, 2026 03:48 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Face-offs still continue’: ITBP chief reveals fresh India-China border tensions in Arunachal | Eiffel Tower women staff row: BAPS monk blames ‘miscommunication’, denies delegation's role | ‘Pen, not stones and guns’: RSS-linked group opens its first office in Kashmir Valley under Muslim leader | First human case of Shamonda virus reported in France; WHO confirms death of immunocompromised patient | ECI rift deepens: RTI reveals 2 Election Commissioners complained to Cabinet Secretary over senior official's order | Tiger Shroff, not Salman Khan, was the main target, probe reveals shocking details | Dammam airport attack: Indian killed, two compatriots injured as Saudi Arabia faces fresh strikes | ‘Among others’: Macron takes swipe at Trump over France unrest, calls foreign leaders’ remarks ‘stupid’ | ‘Specific threat-related inputs’: Delhi Police blocks Diljit Dosanjh’s Delhi concert | ‘Barbaad kare alfaz mere’: Ranbir Kapoor apologises for Dussehra gaffe in Kolkata
Kerala
Image Credit: Wikimedia Commons

Coronavirus: Kerala to conduct Seroprevalence study to estimate population level immunity

| @indiablooms | Aug 28, 2021, at 04:02 pm

Thiruvananthapuram/UNI: Kerala Government has accorded sanction to conduct Seroprevalence study to estimate the population level immunity (level of herd immunity induced by both natural and the COVID vaccines) in the state.

The study aims to get an insight into the dynamics of the COVID pandemic and suggest strategies for prevention and control of the disease, according to the order issued by Principal Secretary (Health) Rajan Namdev Khobragade.

As Kerala faced the second wave of COVID-19 during the months of May and June 2021, the population behaviour, mobility and other factors are changing with the various stages of easing of the restrictions.

The primary objectives of the study are to estimate the seroprevalence of SARS CoV-2 IgG antibodies among ≥18 year old population, antenatal women attending antenatal care clinics, children aged 5 to 17 years, tribal population aged ≥18 yrs in rural parts of districts, people ≥18yrs in coastal areas and people ≥18yrs in slums areas in corporations of Kerala.

Read: India administers over 1 crore vaccine doses in a single day, PM Modi appreciates

The secondary objectives are to study the determinants of seropositivity among the various study populations, among the categories of vaccination status in the study populations and estimate the case to infection ratio and infection fatality ratio in the general population.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.